Skip to the page

Data / Form D filings / ARMR Sciences Inc.

ARMR Sciences Inc.: Form D filing

ARMR Sciences Inc., a biotechnology company in New York, NY, filed a Form D with the SEC in 2025. The latest, on August 29, 2025, reports an offering of $30 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12 E 49TH ST, New York, NY, 10017
Phone
(212) 874-0609
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
2082685

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 29, 2025New notice$30,000,000$0$30,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Shon RemichExecutive Officer
Jeffrey HwangDirector
Nicholas JacobExecutive Officer
Collin GageExecutive Officer, Director
Kenneth KohnDirector
Denise ShullDirector

Other biotechnology companies in New York that filed recently

Every Form D from the week of Aug 25, 2025 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ARMR Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.